This Cancer Immunology Research study highlights CD229 as an immunotherapeutic target in multiple myeloma and demonstrates that dual-targeting CAR T cells against CD229 and BCMA may overcome resistance due to BCMA antigen loss, paving the way for more durable antitumor responses. buff.ly/Qyrnypq

Molecular Cancer Therapeutics Editor-in-Chief, Daniel K. Nomura, PhD, discusses his vision for the journal and some of the most promising areas of research in cancer therapeutics today. Watch the full interview: buff.ly/bwsu7dV

The AACR Journals are committed to fast, high-quality peer review. Learn more about average decision times and the review process. buff.ly/eWpzEnw

Watch our interview with Moray J. Campbell, PhD, MS, recipient of the 2025 Cancer Research Communications Award for Outstanding Journal Article, to learn more about his research: buff.ly/oaTYFUb

Molecular Cancer Therapeutics is the central hub for #FirstDisclosures of novel cancer therapeutics. Catch up on the latest articles: buff.ly/4JBMh5y

For pediatric cancer patients vulnerable to hearing loss from platinum-based drugs, there is a critical need to understand and combat a potentially lifelong disability. But a recent study in Cancer Research Communications offers a hopeful path forward. Read the article: buff.ly/h8rVPzA

Paola Neri presents data from her recent Blood Cancer Discovery paper, "Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies" at #IMS25. Read the article: buff.ly/vlQra5A

Just published! Read the Special Report in Clinical Cancer Research highlighting the AACR Cancer Progress Report 2025: Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact buff.ly/oaq33Cf

Read the abstracts from @theaacr.bsky.social Special Conference in Cancer Research: Advances in Ovarian Cancer Research here in the September 15 issue of Cancer Research: buff.ly/wDFguLS #AACRovca25

Attending #AACRdisp25? Read the Cancer Health Disparities article collection: buff.ly/xDUb78D

Attending #IMS25? Read the recently updated Myeloma article collection: buff.ly/BfdEBCi

Attending the #IMS25 Regulatory Session? Check out this review article on how MRD received FDA approval as an early endpoint for myeloma and what this means for accelerated drug approval: buff.ly/jCeKyZp

Learn how AACR’s #openaccess, peer-reviewed journal—Cancer Research Communications—supports authors from presubmission through publication: buff.ly/NTCCGgR

If you are attending #AACRovca25, meet Clinical Cancer Research Assistant Editor Rachel Hodge, PhD, during breakfast on Saturday, September 20th from 7AM – 8AM in the Colorado Ballroom Foyer.

Thank you to our peer reviewers for your continued dedication to the AACR Journals! #PeerReviewWeek #PRW2025

Are you Attending #AACRdisp25? Don’t miss the AACR Journals’ editors breakfast on Saturday, September 20th from 8AM – 9AM in Key Ballroom 3, 4, 6, featuring @adscheid3.bsky.social, PhD, of Cancer Research Communications and @i-mei.bsky.social, PhD, of Cancer Discovery.

The AACR Journals offers the Guaranteed Peer Review program. Members who peer review at least three manuscripts for one or more AACR journals can qualify to have their own submitted manuscript be automatically sent for external peer review. #PeerReviewWeek #PRW2025 Learn more: buff.ly/Wh1F3e7

Today at #IMS25 Guido Lancman is discussing "Factors Influencing Infection Risk in MM." Read his related article on infection prevention by IVIg, "Infections with BCMAxCD3 Bispecific Antibodies." buff.ly/F4Thoyq

Attending Bruno Paiva's talk at #IMS25? Read his paper "Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel" buff.ly/EFOYx3S

Read the abstracts from @theaacr.bsky.social Special Conference on The Science of Cancer Health Disparities here in the September issue of Cancer Epidemiology, Biomarkers & Prevention: buff.ly/4SSEDmG #AACRdisp25

If you are attending #AACRdisp25, meet the AACR Journals’ editors during breakfast on Saturday, September 20th from 8AM – 9AM in Key Ballroom 3, 4, 6, featuring @adscheid3.bsky.social, PhD, of Cancer Research Communications and @i-mei.bsky.social, PhD, of Cancer Discovery.

Clinical Cancer Research Assistant Editor Rachel Hodge, PhD, will be attending @theaacr.bsky.social Special Conference on Ovarian Cancer. If you have a question about the journal or are interested in discussing your research, please reach out to her at [email protected]. #AACRovca25

The Cancer Health Disparities collection details social and geographical factors driving variation in access to healthcare, ancestry-linked biological differences in cancer genetics and physiology, and disparate disease outcomes among diverse populations in the US and globally. buff.ly/S8rHsiO

Catch Paola Neri presenting at #IMS25 on "Role of target/tumor as mechanism of resistance to CAR T-cell redirecting therapies." Check out her recently published related paper, "Timing multiple myeloma immune-resistance." buff.ly/vlQra5A

At the AACR Cancer Progress Report 2025 release, Sandra McAllister touches on her paper in Cancer Discovery, "Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer." Read the article: buff.ly/fYyGBgI

IMS President, Philippe Moreau, presents information on his recently published Blood Cancer Discovery In Focus piece at the IMS Annual Meeting Opening Ceremony #IMS25 Read the article: buff.ly/m3ShFMq

Blood Cancer Discovery Assistant Editor Abigail Cleveland, PhD, is attending #IMS25. If you have a question about the journal or are interested in discussing your research, please reach out to her at [email protected].

Blood Cancer Discovery author Krina Patel is beginning her talk at #IMS25 on "Improving patient care: lessons from real-world evidence." Read her recent paper, "Real-World Outcomes with Teclistamab in Relapsed Myeloma" buff.ly/MaCYoJK

Cancer Discovery @i-mei.bsky.social, PhD, will be attending @theaacr.bsky.social Special Conference on the Science of Cancer Health Disparities. If you have a question about the journal or are interested in discussing your research, please reach out to her at [email protected]. #AACRdisp25

To increase the opportunities for early career researchers to gain knowledge and experience in peer review, Cancer Epidemiology, Biomarkers & Prevention offers a Reviewer Training Program. #PeerReviewWeek #PRW2025 buff.ly/6NqgexV

Read recently updated articles in the Myeloma collection: buff.ly/BfdEBCi #IMS25

Members of the 2023 AACR Childhood Cancer Predisposition and Surveillance International Workshop published a series of articles in the AACR journal Clinical Cancer Research, which are freely available to readers online. Check out Pediatric Oncology series:

Cancer Research Communications’ @adscheid3.bsky.social, PhD, will be attending @theaacr.bsky.social Conference on the Science of Cancer Health Disparities. If you have a question about the journal or are interested in discussing your research, reach out to him at [email protected]. #AACRdisp25

The Tumor Microenvironment collection explores many of the components of the tumor microenvironment, including the myriad immune cell types, fibroblasts, extracellular matrix constituents, and soluble factors. Check it out: buff.ly/ZenILMb

An AACR study presented at the 10th International Congress on Peer Review & Scientific Publication found authors & reviewers for the AACR journals are increasingly using generative AI, but only a small proportion are disclosing this usage as required by the journals. @peerreviewcongress.bsky.social

Skipping the Scalpel: Can Some Patients Avoid Surgery, Preserve Their Organs, and Still Beat Cancer? buff.ly/DVZdEZb Check out these related Clinical Cancer Research articles about organ and structure preservation:

Read article collections featuring impactful, cutting-edge research on Developmental Therapeutics, Early Detection, and more: buff.ly/Oi8by86

Today is #WorldLymphomaAwarenessDay Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques and bringing innovative therapies to patients. buff.ly/q3NmZc2

In this recently published article in Cancer Immunology Research, the authors report a new method for producing functional cDC1s in larger quantities, providing a way to harness their potential for fighting cancer. Read more: buff.ly/3im2mlf

In the September issue of Blood Cancer Discovery: “Refined Disease Classification in Myeloid Neoplasms.” Watch the interview with Dr. Sanam Loghavi. buff.ly/Nd05b1T Read the article: buff.ly/vniHKPM

Pictured here is Dr. Christopher Flowers, Blood Cancer Discovery Scientific Editor, who featured the “Microenvironment Characteristics of Follicular Lymphoma” study as a future approach to guiding therapy selection. Read the article: buff.ly/OBictLV #SOHO25

Watch our interview with Minah Kim, PhD, recipient of the 2025 Cancer Research Early Career Award, to learn more about her research: buff.ly/cxZqOIR

The work of the 2025 AACR Journal Award recipients showcased insights with the potential to inform approaches to cancer prevention and care worldwide. Learn more on the #AACRBlog: buff.ly/ORGUU7x

Tingting Zhai, PhD, recipient of the 2025 Cancer Prevention Research Award for Outstanding Journal Article, discusses a surprising but important finding from the CANTOS clinical trial in the clip below. To learn more, watch the full interview: buff.ly/CIW77sY

A study led by #CLÍNIC-#IDIBAPS and published in Blood Cancer Discovery shows that the gut microbiota can predict and enhance patient response to one of the most innovative immunotherapies against cancer. buff.ly/2aEXUWp Read the press release: buff.ly/rQ4nN3I @idibaps.bsky.social

Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/O6OYSDp

September is #LeukemiaAwarenessMonth. Read this collection from Blood Cancer Discovery showcasing advances in acute leukemia encompassing articles on mechanisms of pathogenesis, new therapeutic approaches and molecular determinants of clinical response and resistance. buff.ly/GIUGLct

Dr. Ghayas C. Issa presents on his newly published review in Blood Cancer Discovery, Combination Strategies with Menin Inhibitors for Acute Leukemia. Read the review: buff.ly/QYTyVjN

Watch our interview with Christian Bauer, MD, and his coauthor Veronika Lutz, PhD, corecipients of the 2025 Cancer Immunology Research Award for Outstanding Journal Article, to learn more about their research: buff.ly/QfECChq

Check out this recent #AACRBlog on Applying Artificial Intelligence to Drive Cancer Research: buff.ly/NohXkUO To learn about more AI applications across the cancer research spectrum, check out the new special series from Cancer Research: buff.ly/DlizFen